Switch to:
GuruFocus articles
Headlines from internet
Oct-20-17$87.23 (+1.01%)
01:57PMMerck to cut 1,800 US sales jobs, add 960 in chronic care cnbc
07:47AMPharma Stock Roundup: Beat & Raise Quarter from J&J, Allergan Hit by Restasis Ruling Zacks
Oct-19-17$86.36 (+0.73%)
08:51AMCan ImmunoGen's Key Pipeline Cancer Candidate Drive Growth? Zacks
08:20AMTeva Submits BLA to FDA for Migraine Candidate Fremanezumab Zacks
08:00AMNovartis Reports Positive Results on Thrombocytopenia Drug Zacks
Oct-18-17$85.73 (-0.38%)
03:21PMWhat to Expect from Big Pharmas After J&J's Solid Q3 Results? Zacks
08:33AM10 Stunning Numbers You Need to Know About Breast Cancer Fool
06:42AMEli Lilly (LLY) to Report Q3 Earnings: What's in Store? Zacks
Oct-17-17$86.06 (+0.13%)
09:12PM3 Things You Won't Learn by Focusing on Johnson & Johnson's Headline Figures in Its Q3 Report Fool
10:13AMJ&J: Strong Earnings Is the Best Medicine Barron's
Oct-16-17$85.95 (-0.69%)
01:04PMBiotech Forum Daily Digest Aratana Therapeutics Back Spotlight Seekingalpha
11:21AMSanofi Upward Trajectory 2017 Seekingalpha
Oct-15-17
08:00AM3 Things Biotech Learn Today October 15 2017 Seekingalpha
Oct-13-17$86.55 (+0.14%)
04:59PMRoche Allergan Approaches Alzheimers Seekingalpha
03:14PM5 Large-Cap Drug Stocks Well Poised to Beat on Q3 Earnings Zacks
11:40AMDaily Pharma Scoop Seeking Alpha Interview Spark Adcom Nod Luxturna Pfizer Lyrica Approval Seekingalpha
10:18AMCancer Space Update: Lung & Breast Cancer Studies in Focus Zacks
08:02AMLilly's Verzenio Gets Priority Review in First-Line Setting Zacks
07:06AMPharma Stock Roundup: Pfizer Mulls Options for Consumer Healthcare, LLY's Pipeline Setback Zacks
06:36AMIDEX (IEX) To Report Q3 Earnings: What's in the Cards? Zacks
06:09AMMccormicks Acquisition Good Cramers Lightning Round 10 12 17 Seekingalpha
Oct-12-17$86.43 (+0.43%)
08:17PMMazor Robotics, Iridium, ZAGG: 'Mad Money' Lightning Round theStreet
02:30PMMerck Will Not Seek Approval for CETP Inhibitor Anacetrapib Zacks
01:07PMLower Volatility Stock Portfolio Retirees Others Seekingalpha
12:43PMJohnson & Johnson: Another Day, Another Bullish Analyst Barron's
Oct-11-17$86.06 (-0.12%)
01:40PMPfizer: Who Will Pay $14B for Advil? Barron's
11:46AMBiotech Analysis Central Daily Pharma News Seekingalpha
09:40AMLilly's (LLY) Verzenio Fails in Phase III Lung Cancer Study Zacks
09:29AMSeattle Genetics Begins Phase II Study of Cancer Candidate Zacks
07:00AM3 Things Biotech Learn Today October 11 2017 Seekingalpha
Oct-10-17$86.16 (-1.02%)
10:20AMEli Lilly Loses Some Luster Barron's
Oct-09-17$87.05 (-0.03%)
09:00AMPfizer Growth Trajectory Locked Ready Launch Seekingalpha
05:11AMDaily Insider Ratings Round 10 5 17 Yuma Wkhs Infi Msf Gec Seekingalpha
Oct-06-17$87.08 (-0.65%)
01:31PMBiogen Problems Strategy Make Avoid Seekingalpha
Oct-05-17$87.65 (+0.79%)
08:55PMValuation Dashboard Healthcare Update Seekingalpha
Oct-03-17$86.45 (+0.12%)
03:32PMJohnson And Johnson Best Breed Healthcare Seekingalpha
Oct-02-17$86.35 (+0.95%)
10:22AMAntares Numerous Upcoming Catalysts Seekingalpha
05:19AMStarting Point Big Pharma Novartis Sanofi Clear Hurdles Seekingalpha
Sep-29-17$85.54 (+0.64%)
11:08AMEli Lilly Strives Counteract Rivals Seekingalpha
10:10AMVictory Formation Long Short Portfolio Update September 2017 Seekingalpha
08:00AM3 Things Biotech Learn Today September 29 2017 Seekingalpha
Sep-28-17$85 (+0.41%)
02:55PMAbbvie Transitions Growth Stock Income Play Seekingalpha
Sep-27-17$84.65 (+0.51%)
10:12AMDaily Pharma Scoop Nektars Potential Axovant Finally Fails Ptct Adcomm Tomorrow Seekingalpha
Sep-21-17$83.33 (+1.6%)
09:03AMHold Zoetis 2017 Seekingalpha
Sep-12-17$82.17 (-0.56%)
05:19PMLilly Cuts Back Seekingalpha
02:36PMKura Oncology Radar Biotech Seekingalpha
12:38PMAbbvie Faint Heart Seekingalpha
Sep-11-17$82.63 (-0.35%)
04:57PMWeekly Pharma Scoop Valeants Crl Resolution Eagle Undervalued Array Positive Results Seekingalpha
Sep-10-17
12:25PMWeek Review China Pharma Continues Record Deal Pace 2 Billion New Announcements Seekingalpha
Sep-02-17
07:15AMEagle Pharmaceuticals: Strong Upside Potential Despite Recent Heatstroke Stumble Seekingalpha
Aug-31-17$81.29 (+0.99%)
11:55AMEli Lilly Offers Consistent Dividends, But Stock Shows Uneven Performance Seekingalpha
08:00AM3 Things In Biotech You Should Learn Today: August 31, 2017 Seekingalpha
Aug-30-17$80.49 (+2.47%)
07:51AMMomentum Indicated Avoids/Sells In Blue-Chip Health Care Seekingalpha
Aug-25-17$78.79 (-0.09%)
09:00AM3 Things In Biotech You Should Learn Today: August 25, 2017 Seekingalpha
Aug-24-17$78.86 (+0.91%)
12:14AMDiagnosing Merck (Part 2 Of 2) Seekingalpha
Aug-23-17$78.15 (-0.14%)
11:06PMVictory Formation Long/Short Portfolio Update - August 2017 Seekingalpha
Aug-22-17$78.26 (+1.14%)
05:13PMLigand: Situated For Growth Seekingalpha
Aug-21-17$77.38 (+0.4%)
03:57PMNovo Nordisk's Next Crown Jewel Seekingalpha
Aug-20-17
08:32AMWeek In Review: China's Life Science Deals Top $1.4 Billion For Week Seekingalpha
Aug-18-17$77.07 (-0.94%)
08:58AMNovo And Lilly Head For Diabetes Pricing Battle Seekingalpha
Aug-16-17$80.69 (-1.25%)
08:59PMVery Cautious On AbbVie's Fundamentals Seekingalpha
12:12PMBiogen's Alzheimer's Hope Tops The Sector's Most Valuable Pipeline Projects Seekingalpha
Aug-14-17$81.49 (+0.42%)
05:44AMA Portfolio Of Biotech Growth Seekingalpha
Aug-11-17$81.15 (-1.1%)
09:00AM3 Things In Biotech You Should Learn Today: August 11, 2017 Seekingalpha
Aug-09-17$82.57 (+0.73%)
03:39PMEsperion's Triple Combo Hits A Home Run Seekingalpha
Aug-08-17$81.97 (-0.12%)
09:00AM3 Things In Biotech You Should Learn Today: August 8, 2017 Seekingalpha
Aug-07-17$82.07 (-0.29%)
04:02PMPair Trade Big Pharma - One Real Deal, One Pretender? Celgene Vs. Lilly Seekingalpha
08:39AMPfizer Highly Recommended By Panel, Time For FDA Showdown Seekingalpha
Aug-05-17
01:27PM4 Dividend Value Stocks In An Up Market Seekingalpha
Aug-03-17$81.93 (+0.13%)
06:22AMDaily Insider Ratings Round Up 8/1/17: IFF, RETA, TDC Seekingalpha
Aug-02-17$81.82 (-0.67%)
09:50AMAbbVie, Part 2: Its Strengths Beyond Humira, And Weakness Seekingalpha
Aug-01-17$82.37 (-0.35%)
03:32PMRheumatoid Arthritis Safety Spotlight Widens Seekingalpha
10:25AMTough Competition For Valeant's Newly Approved Drug, SILIQ Seekingalpha
08:35AMLaunch Of SILIQ Makes Valeant A Great Short Opportunity Seekingalpha
Jul-31-17$82.66 (-0.53%)
02:44PMOpinions Split On Ox40 Seekingalpha
Jul-28-17$83.1 (+0.1%)
09:00AM3 Things In Biotech You Should Learn Today: July 28, 2017 Seekingalpha
Jul-27-17$83.02 (+1.44%)
02:43PMGilead: The Greyhound Leaves The Doghouse Seekingalpha
01:02PMNektar Therapeutics: Further Upside Ahead Seekingalpha
09:45AMAmgen Reports Q2: Short- And Long-Term Considerations Seekingalpha
Jul-26-17$81.84 (-0.43%)
03:11PMGlaxo Gets Out The Axe Seekingalpha
03:07PMOlumiant Clot Signal Echoes Xeljanz Experience Seekingalpha
Jul-25-17$82.19 (-3.01%)
04:10PMNektar Makes A Stride Forward In Resolving Autoimmune Diseases Seekingalpha
10:06AMIs Aratana Your Porfolio's Best Friend? Seekingalpha
09:17AMEli Lilly and Company 2017 Q2 - Results - Earnings Call Slides Seekingalpha
07:22AMLilly Hopes To Bloom Through Nektar Attraction Seekingalpha
Jul-24-17$84.74 (+0.09%)
11:31PMEarnings Preview: What Might Be Expected From Caterpillar, Eli Lilly And General Motors? Seekingalpha
Jul-21-17$84.66 (-0.11%)
03:28PMIgnyta Lights The Fire Seekingalpha
10:32AMUnited Therapeutics Losing The Crown Jewels; 20% EPS Downgrades Ahead Seekingalpha
Jul-19-17$84.23 (+0.63%)
01:51PMImmunogen Finally Moving 'FORWARD'? Seekingalpha
08:57AMNovartis, Glaxo and Lilly Bigly Back New Biotech Barron's
Jul-18-17$83.7 (+0.07%)
01:58PMInvestors Waiting In BioLineRx Seekingalpha
11:55AMAmgen Receives CRL For Osteoporosis Drug: What's The Next Step? Seekingalpha
09:34AMJohnson & Johnson's Tremfya: A Potential Blockbuster Drug Seekingalpha
08:58AMEarnings Preview: Valeant Pharmaceuticals Seekingalpha
Jul-17-17$83.64 (-0.84%)
03:55PMQuintiles IMS: A Novel Way To Invest In Biopharma Seekingalpha
03:00PMJohnson & Johnson: Approval Of TREMFYA Is Huge Win For Shareholders Seekingalpha
Jul-13-17$84.02 (+0.62%)
09:30AM3 Things In Biotech You Should Learn Today: July 13, 2017 Seekingalpha
Jul-12-17$83.5 (+1.4%)
03:28PMEli Lilly's Abemaciclib: Better Than Competition In Breast Cancer? Seekingalpha
01:01PMA Chinese Oncology Company With Great Potential Seekingalpha
Jul-11-17$82.35 (+0.09%)
05:01PMAC Immune: A Compelling Speculative Investment Seekingalpha
Jul-10-17$82.28 (-0.01%)
08:22PMAstraZeneca Can Prove To Be A Top Notch Investment Opportunity In 2017 Seekingalpha
02:09PMWill You Be Ready For The Next Market Downturn? Seekingalpha
Jul-07-17$82.29 (+0.85%)
09:30AM3 Things In Biotech You Should Learn Today: July 7, 2017 Seekingalpha
Jul-05-17$82.7 (+0%)
05:45PMAlkermes Preliminary Phase 3 Data Leaves A Welcomed Impression Seekingalpha
12:03PMA Look At Geron's Potential Myelofibrosis Competition Seekingalpha
Jul-03-17$82.7 (+0.49%)
04:47PMSocial Media Hysteria And Massive Discount After Alder's Positive Results Make It A Compell... Seekingalpha
Jun-30-17$82.3 (-0.48%)
02:58PMThe Alder Phase-3 Results Do Not Predict Market Failure Seekingalpha
Jun-29-17$82.7 (-0.48%)
06:49AMA Look At The Competition Geron Could Face In Myelodysplastic Syndromes Seekingalpha
Jun-28-17$83.1 (+0.07%)
04:36PMMerck's Cautious Statement Suggests Slim Chances Of Anacetrapib Success Seekingalpha
03:54PMChina's Dialysis Market: Potential For Growth Driven By Diabetes And Aging Population Seekingalpha
Jun-20-17$82.75 (+0.5%)
02:26PMEli Lilly and Company (LLY) Updates On Pain Portfolio - Slideshow Seekingalpha
May-11-17$80.22 (-1.02%)
05:16PMKeytruda Gets Hot And Propels Merck: Analysis Seekingalpha
May-10-17$81.05 (+0.32%)
03:26PMThere Are Failures, You Know Seekingalpha
08:51AMPhysicians Look For Progress In Mesothelioma Seekingalpha
May-09-17$80.79 (+0.15%)
05:17PMAccelerated Pharma Plans $12 Million IPO Seekingalpha
May-08-17$80.67 (-2.23%)
04:00PMIncyte Below $120: A 'Buy' Range For This Emerging Biotech? Seekingalpha
12:43PMRadius Health's Tymlos: How It Compares To The Competition Seekingalpha
May-07-17
05:32AMAstraZeneca's New Drug: Too Little, Too Late? Seekingalpha
May-05-17$82.51 (-0.64%)
07:07AMBlue-Chip Long/Short Portfolio Example: Victory Formation Edition Seekingalpha
May-02-17$81.7 (-0.15%)
08:08PMFlurry Of FDA Activity Raises Hopes For 2017 Approval Tally Seekingalpha
May-01-17$81.82 (-0.29%)
05:09PMUroGen Pharma Readies $45 Million IPO Seekingalpha
02:54PMMannKind: Mann Trust Executors Are Selling Massive Numbers Of Common Shares Seekingalpha
Apr-30-17
05:26AMWeek In Review: Cathay Fortune Pays $186 Million For German Diagnostic Company Seekingalpha
Apr-28-17$82.06 (+0.9%)
02:39PMCalling All Heart Docs - Your Diabetes Drugs Need You Seekingalpha
Apr-27-17$81.33 (+0.46%)
01:17PMG1 Therapeutics Seeks $115 Million IPO Seekingalpha
09:54AM3 Things In Biotech You Should Learn Today: April 28, 2017 Seekingalpha
Apr-26-17$80.96 (-0.3%)
10:27AMLilly Assures Market As Diabetes Stumbles Seekingalpha
05:04AMEli Lilly: Key Q1 2017 Insights Seekingalpha
Apr-25-17$81.2 (-2.66%)
12:51PMBiogen Jumps On Q1 Results: Analysis Seekingalpha
08:46AMEli Lilly and Company 2017 Q1 - Results - Earnings Call Slides Seekingalpha
Apr-24-17$83.42 (+1.87%)
02:10PMEarnings Preview: Lilly, Lockheed Martin, And CAT Report Tomorrow Seekingalpha
10:50AMA Physician Analyzes Valeant's Siliq, As The Stock Crashes Seekingalpha
08:15AMIncyte: Little Upside Left Seekingalpha
07:31AMGame Plan For The Week - Cramer's Mad Money (4/21/17) Seekingalpha
Apr-19-17$80.89 (-0.38%)
04:20PMBiolineRx: COMBAT Engagement Seekingalpha
Apr-18-17$81.2 (-1.43%)
04:03PMFor $300M, Biogen Beefs Up Its Alzheimer's Attack Seekingalpha
02:08PMIncyte: Buy On The Drop? Seekingalpha
01:59PMIs This Sudden Flight To Safety Temporary? Seekingalpha
01:27PMOlumiant Setback Opens The Door To Rivals Seekingalpha
Apr-15-17
08:00AM3 Things In Biotech You Should Learn Today: April 15, 2017 Seekingalpha
Apr-13-17$85.88 (-0.43%)
09:44AMLarge Cap Biotech Review Pre-Earnings, Part 2 Seekingalpha
Apr-11-17$85.93 (+0.54%)
03:05PMFirst-Quarter Deal Making Shows Glimmers Of Growth Seekingalpha
Apr-07-17$85.32 (-0.05%)
03:14PMBoehringer Awaits Jardiance Lift-Off Seekingalpha
Dec-31-69
07:00PMLate Stage Cancer Drug Failure Sinks Eli Lilly: LIVE MARKETS BLOG theStreet
07:00PMLate Stage Cancer Drug Failure Sinks Eli Lilly: LIVE MARKETS BLOG theStreet
07:00PMEarnings Calendar: LIVE MARKETS BLOG theStreet
07:00PMEarnings Calendar: LIVE MARKETS BLOG theStreet
07:00PMTake That Amazon, Walmart Remains Bullish on Online Future: LIVE MARKETS BLOG theStreet
07:00PMTake That Amazon, Walmart Remains Bullish on Online Future: LIVE MARKETS BLOG theStreet
07:00PMOpening Bell: LIVE MARKETS BLOG theStreet
07:00PMOpening Bell: LIVE MARKETS BLOG theStreet
07:00PMP&G Vote May Be Too Close to Call Today, Peltz Says: LIVE MARKETS BLOG theStreet
07:00PMP&G Vote May Be Too Close to Call Today, Peltz Says: LIVE MARKETS BLOG theStreet
07:00PMAirline Stocks Take Flight on Strong Metrics: LIVE MARKETS BLOG theStreet
07:00PMAirline Stocks Take Flight on Strong Metrics: LIVE MARKETS BLOG theStreet
07:00PMRetirees and Legacy Investors Are Unhappy With P&G Peltz Says :LIVE MARKETS BLOG theStreet
07:00PMRetirees and Legacy Investors Are Unhappy With P&G Peltz Says :LIVE MARKETS BLOG theStreet
07:00PMP&G Will Listen to Peltz as Company's Largest Shareholder :LIVE MARKETS BLOG theStreet
07:00PMP&G Will Listen to Peltz as Company's Largest Shareholder :LIVE MARKETS BLOG theStreet
07:00PMTrian to Contest P&G Vote :LIVE MARKETS BLOG theStreet
07:00PMTrian to Contest P&G Vote :LIVE MARKETS BLOG theStreet
07:00PMNFL Caves to Trump, Considers Regulating Anthem Protest: LIVE MARKETS BLOG theStreet
07:00PMNFL Caves to Trump, Considers Regulating Anthem Protest: LIVE MARKETS BLOG theStreet
07:00PMMonday Night Football Posts Lowest Ratings of the Season: LIVE MARKETS BLOG theStreet
07:00PMMonday Night Football Posts Lowest Ratings of the Season: LIVE MARKETS BLOG theStreet
07:00PMClosing Bell: LIVE MARKETS BLOG theStreet
07:00PMClosing Bell: LIVE MARKETS BLOG theStreet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK